Check Cap Ltd is an Israel-based clinical-stage medical diagnostics company. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.
Código da empresaCHEK
Nome da EmpresaCheck Cap Ltd
Data de listagemFeb 19, 2015
CEOMr. Alex Ovadia
Número de funcionários- -
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 19
Endereço29 Abba Hushi Ave.
Cidade
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísIsrael
Código postal3009000
Telefone97248303401
Sitehttps://check-cap.com/
Código da empresaCHEK
Data de listagemFeb 19, 2015
CEOMr. Alex Ovadia
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.

Sem dados